How Will the Most Favored Nation (MFN) Policy Influence Medicines Pricing and Access in Europe and How Should Policy Makers Respond?

Mon, Nov 9, 2026 · 1:45–2:45 PM CET Hall E1, Level 0, Austria Center Vienna

About this session

Purpose: The Most Favoured Nation (MFN) policy being pursued by the US administration has the potential to influence prices and access for new pharmaceuticals across high income countries. This workshop will identify how MFN is likely to affect access and pricing globally and what European policymakers should do in response.

Speakers

Sean D Sullivan

University of Washington

Moderator
IRIA ALVAREZ NOVOA IGLESIAS

Speaker
Beth Woods

University of York

Speaker